GENEVA—The use of combinations including checkpoint inhibition with other immunotherapies, other targeted therapies and chemotherapy was discussed at the European Lung Cancer Conference by Martin Reck
GENEVA—The use of combinations including checkpoint inhibition with other immunotherapies, other targeted therapies and chemotherapy was discussed at the European Lung Cancer Conference by Martin Reck MD PhD from the department of thoracic oncology at the Lung Clinic Grosshansdorf near Hamburg, Germany. He gave Oncology Times reporter Peter Goodwin his views about their potential impact on daily oncology practice.